A common BIM polymorphism was identified in TKI-resistant chronic myeloid leukemia cells from East Asian individuals and confirmed to be present in EGFR mutant NSCLC cells as well. This evidence concerns the gene BCL2L11 and non-small cell lung carcinoma.